Trial intelligence / Profile preview

PRGF vs Steroid Supplementation After TMJ Arthrocentesis in Female Patients With TMJ OA

NCT04731233Phase 4Terminated

Sponsor
University of Florida
Start
Mar 2021
Primary completion
Feb 2024
Modality
Cell Therapies
Countries
1
01

Overview

A Phase 4 trial of PRGF-Endoret in temporomandibular joint osteoarthritis, sponsored by University of Florida. Started Mar 2021; status: terminated.

02

Drugs

PRGF-Endoret
03

Conditions

temporomandibular joint osteoarthritis

Beyond the preview

Go deeper on NCT04731233.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04731233.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call